Enoxaparin
CV185-047
Phase 3 small_molecule completed
Quick answer
Enoxaparin for Deep Vein Thrombosis is a Phase 3 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Deep Vein Thrombosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed